Table 3.
First author (year) | Random sequence generation |
Allocation concealment |
Blinding of participants and personnel |
Blinding of outcome assessment |
Complete outcome data or intention-to-treat analysis used |
All outcomes reported |
Gardner-Nix (2008) [34] | No | No | No | No | No | Yes |
Buhrman (2013) [29] | Yes | Yes | No | No | Yes | Yes |
Davis (2013) [33] | Yes | Yes | No | No | Yes | Yes |
Dowd (2015) [30] | Yes | Yes | No | No | Yes | Yes |
Trompetter (2015) [31] | Yes | Unclear | No | No | Yes | Yes |
Younge (2015) [35] | Yes | Yes | No | Yes | No | No |
Ljótsson (2010) [36] | Yes | Yes | No | No | Yes | Yes |
Ljótsson (2011) [38] | Yes | Yes | No | Unclear | Yes | Yes |
Ljótsson (2011) [39] | Yes | No | No | No | Yes | Yes |
Ljótsson (2014) [40] | Yes | Yes | No | Unclear | Yes | Yes |
Thompson (2010) [41] | Yes | Yes | No | No | No | Yes |
Thompson (2015) [42] | Yes | Yes | No | No | Yes | Yes |
Hesser (2012) [43] | Yes | Yes | No | No | Yes | Yes |
Johansson (2015) [44] | No | No | No | No | Noa | Yes |
Zernicke (2014) [45] | Yes | Yes | No | No | Yes | Yes |
Bruggeman-Everts (2015) [47] | No | No | No | No | Yes | Yes |
aIntention-to-treat analysis conducted with a subset of participants but not all.